Frits Van Rhee, MD, PhD
Director of Developmental and Translational Medicine
39 years treating Multiple Myeloma | 850 Multiple Myeloma patients treated annually
Frits van Rhee, M.D., Ph.D., is a Professor of Medicine and Clinical Director of the UAMS Myeloma Center. He earned his medical degree from Erasmus University, Rotterdam, Netherlands, and his Ph.D. at the Imperial College of Science, Medicine and Technology, University of London. Dr. van Rhee trained in Internal Medicine and Hematology in the U.K., and in Bone Marrow Transplantation at John Radcliffe University Hospital in Oxford and the Royal Postgraduate Medical School in London. He holds the Charles and Clydene Scharlau Chair for Hematological Malignancies.
Dr. van Rhee is an international expert on Castleman Disease, with one of the largest populations of Castleman Disease patients in the world. He also is an expert in multiple myeloma and other hematologic malignancies, with a research focus in immunotherapy.
Dr. van Rhee is a member of the International Society for Cellular Therapy, the International Society for Experimental Hematology, the European Group for Bone and Marrow Transplantation, the Royal college of Physicians (U.K.), the Royal College of Pathologists (U.K.), and the American Society of Hematology. He has U.K. board certification in Internal Medicine and Hematology.
University Of Arkansas Medical Sciences: 4301 W Markham St # 816, Little Rock, AR 72205, USA